The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLSDays features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Ms. Sana Alajmovic

Co-Founder & CEO, Sigrid Therapeutics

20 Apr 09:15 Plenary Room NLSDays Grand Opening

Dr. Andrea Ballagi

VP Sales and Marketing, Olink Proteomics

21 Apr 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Ms. Maria Bech

CEO, EpiEndo Pharmaceuticals

20 Apr 09:15 Plenary Room NLSDays Grand Opening

Dr. Karin Conde-Knape

Senior Vice President Global Drug Discovery, Novo Nordisk

20 Apr 09:15 Plenary Room NLSDays Grand Opening

Mr. Olivier Duchamp

Managing Director, NLSDays - VP International BD & Promotion, SwedenBIO

20 Apr 09:15 Plenary Room NLSDays Grand Opening

Ms. Anya Eldan

Vice-President, Israel Innovation Authority

20 Apr 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Dr. Per Falk

President, Ferring Pharmaceuticals

21 Apr 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Mr. Douglas Foerster

Senior Vice President, Pricing & Market Access, Europe, Eversana

Dr. Armend G. Håti

CEO & Co-founder, ClexBio

20 Apr 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Prof. Emma Lundberg

Founder & Chairman, MindForce GameLab

20 Apr 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Ms. Anne Margrethe M. Platou

ESG Analyst, DNB Markets

21 Apr 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Ms. Alice Mattsson

Founder, Pharmista Technologies

21 Apr 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Dr. Lisa Melton

Senior News Editor, Nature Biotechnology

21 Apr 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Ms. Maarit Merla

Head of Business Development, Forendo Pharma

20 Apr 09:15 Plenary Room NLSDays Grand Opening

Dr. Kelle Moley

Deputy Director of Reproductive Health Technologies, Global Health, Bill & Melinda Gates Foundation

21 Apr 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Dr. Victor Neduva

Senior Director Discovery Research, MSD

21 Apr 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Dr. Anders Persson

Executive Director Ecosystem Strategy & Innovation, AstraZeneca

20 Apr 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Dr. João Ribas

Senior Associate, Novo Holdings

20 Apr 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Dr. Patrik Sobocki

Investment Director DeepTech and Life Sciences, Industrifonden

20 Apr 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Prof. Kári Stefánsson

Founder & CEO, deCODE genetics

21 Apr 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Ms. Helena Strigård

CEO, SwedenBIO

20 Apr 09:15 Plenary Room NLSDays Grand Opening

Ms. Masha Strømme

Co-Chair, PAACS Invest

21 Apr 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Dr. Clemens Utschig-Utschig

Head of IT Technology Strategy and CTO, Boehringer Ingelheim

20 Apr 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Dr. Christina Östberg Lloyd

CEO, Pharmiva

21 Apr 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Prof. Margrét Þorsteinsdóttir

Professor Pharmaceutical Sciences, University of Iceland

21 Apr 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease